Home > Healthcare > Medical Devices > Therapeutic Devices > Smart Inhalers Market

Smart Inhalers Market Size

Report ID: GMI3994
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Smart Inhalers Market Size

Smart Inhalers Market size was valued at USD 1.5 billion in 2022 and is estimated to account for USD 3.3 billion by 2032. Smart inhalers are sensor-enabled digital devices used for administration of drugs by inhalation as well as monitoring accurate doses and tracking inhaler usage.

To get key market trends

Download Free Sample

Rising prevalence of several chronic respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma is one of the major factors contributing to the market revenue. For instance, as per the European Academy of Allergy and Clinical Immunology (EAACI) in 2022, approximately 350 million people globally are currently suffering from asthma.

The integration of smart inhalers into telemedicine and remote patient monitoring devices, market of which being worth USD 14 billion in 2022, help to enhance patient care and also helps in managing respiratory conditions more effectively. It enables more timely interventions, reduces the need for in-person visits, and allows for a more personalized and patient-centered approach to healthcare. Thus, remotely monitoring and managing patients with respiratory conditions will positively influence the demand for smart inhalers.

Smart Inhalers Market Report Attributes
Report Attribute	Details
Base Year:	2022
Smart Inhalers Market Size in 2022:	USD 1.5 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	8.6%
2032 Value Projection:	USD 3.3 Billion
Historical Data for:	2018 to 2022
No. of Pages:	135
Tables, Charts & Figures:	192
Segments covered:	Product, Disease Indication, Distribution Channel, and Region
Growth Drivers:	Growing prevalence of respiratory diseases across the globe Technological advancements in smart inhalers Increasing number of partnership agreements between pharma and software companies Increased medical adherence
Pitfalls & Challenges:	Dearth of awareness in developing countries Significant security risks and privacy issues

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global smart inhalers industry size was USD 1.5 billion in 2022 and is estimated to account for USD 3.3 billion by 2032.

COPD held over 57% industry share in 2022 and will augment the market demand by 2032 due to aging population base, rising disease prevalence caused by continued exposure to risk factors such as tobacco smoke and air pollution, coupled with improved disease diagnosis.

U.S. smart inhalers market accounted for USD 520 million in 2022 and is predicted to witness substantial growth through 2032 owing to technological advancements coupled with substantial healthcare expenditure.

Adherium, Propeller Health, Nemera, GlaxoSmithKline Plc., Novartis AG, Aptar Group Inc, AstraZeneca Plc, Findair Sp. Z.o.o., BioCorp, Zeolr Technologies Pvt Ltd., Vectura Group Plc., Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim International GmbH.